Details for New Drug Application (NDA): 020934

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

NDA 020934 describes LUXIQ, which is a drug marketed by Mylan and is included in one NDA. It is available from one supplier. Additional details are available on the LUXIQ profile page.

The generic ingredient in LUXIQ is betamethasone valerate. There are sixty-six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the betamethasone valerate profile page.

Summary for 020934

Tradename:	LUXIQ
Applicant:	Mylan
Ingredient:	betamethasone valerate
Patents:	0
Formulation / Manufacturing:	see details

Pharmacology for NDA: 020934

Mechanism of Action	Corticosteroid Hormone Receptor Agonists

Medical Subject Heading (MeSH) Categories for 020934

Anti-Inflammatory Agents
Glucocorticoids

Suppliers and Packaging for NDA: 020934

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
LUXIQ	betamethasone valerate	AEROSOL, FOAM;TOPICAL	020934	NDA AUTHORIZED GENERIC	Mylan Pharmaceuticals Inc.	0378-8180	0378-8180-50	50 g in 1 CAN (0378-8180-50)
LUXIQ	betamethasone valerate	AEROSOL, FOAM;TOPICAL	020934	NDA AUTHORIZED GENERIC	Mylan Pharmaceuticals Inc.	0378-8180	0378-8180-99	100 g in 1 CAN (0378-8180-99)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	AEROSOL, FOAM;TOPICAL			Strength	0.12%
Approval Date:	Feb 28, 1999	TE:	AB	RLD:	Yes

Expired US Patents for NDA 020934

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Mylan	LUXIQ	betamethasone valerate	AEROSOL, FOAM;TOPICAL	020934-001	Feb 28, 1999	See Plans and Pricing	See Plans and Pricing
Mylan	LUXIQ	betamethasone valerate	AEROSOL, FOAM;TOPICAL	020934-001	Feb 28, 1999	See Plans and Pricing	See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.